Where to invest $50,000 in ASX shares

Analysts think these shares could be great destinations for your hard-earned money.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

If you are lucky enough to be sitting on $50,000 and wondering how to put it to work in the share market, then read on.

With interest rates falling and long-term growth back in focus, now could be a great time to build a high-quality ASX share portfolio aimed at capital appreciation.

But rather than chasing short-term trades or speculative names, investors may want to consider businesses with proven track records, strong global expansion, and resilient earnings.

With that in mind, here are five standout ASX shares that analysts think could form the foundation of a smart, long-term portfolio. They are as follows:

A happy young couple lie on a wooden deck using a skateboard for a pillow.

Image source: Getty Images

Cochlear Ltd (ASX: COH)

Cochlear is a global leader in hearing implants technology. With an ageing global population and rising rates of hearing loss, demand for Cochlear's products is only expected to increase over the next decade. The company also invests heavily in R&D, which keeps it ahead of the pack with next-generation devices.

Last week, UBS upgraded its shares to a buy rating with a $325.00 price target.

REA Group Ltd (ASX: REA)

Another ASX share to look at with the $50,000 is REA Group. It is the name behind realestate.com.au, which dominates the online property advertising space in Australia. While the housing market moves in cycles, REA Group has built an incredibly sticky platform with pricing power and deep competitive moats.

Bell Potter is bullish on REA Group and has a buy rating and $267.00 price target on its shares.

ResMed Inc. (ASX: RMD)

ResMed is a major player in the treatment of obstructive sleep apnoea and other sleep and breathing disorders. While concerns around weight-loss drugs spooked the market last year, ResMed has continued to post strong results, including robust mask sales, margin expansion, and double-digit earnings growth. It also benefits from an ageing population and increasing awareness of sleep health.

Macquarie has an outperform rating and $48.00 price target on this ASX share.

WiseTech Global Ltd (ASX: WTC)

WiseTech could be an ASX share to buy with the $50,000. It is a global logistics software provider, best known for its CargoWise platform. It serves some of the world's largest freight forwarders and is capitalising on the structural shift toward digital supply chain management. Recurring revenue, global customer wins, and ongoing product innovation give WiseTech a long runway for growth.

The team at Macquarie has an outperform rating and $152.70 price target on its shares.

Xero Ltd (ASX: XRO)

Finally, Xero could be worth considering. It offers cloud-based accounting software to small and medium-sized businesses. It is one of the most recognisable tech names in the region, with a sticky, subscription-based model and strong international growth potential. And with 4.4 million subscribers on its platform and an estimated 100 million total addressable market, it still has a very long growth runway.

Morgan Stanley has an overweight rating and $220.00 price target on its shares.

Motley Fool contributor James Mickleboro has positions in Cochlear, REA Group, ResMed, WiseTech Global, and Xero. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Cochlear, Macquarie Group, ResMed, WiseTech Global, and Xero. The Motley Fool Australia has positions in and has recommended Macquarie Group, ResMed, WiseTech Global, and Xero. The Motley Fool Australia has recommended Cochlear. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Growth Shares

Purple tech growth chart.
Growth Shares

2 wonderful ASX All Ords stocks I'd buy today

These stocks could deliver great returns. Here’s why…

Read more »

Cheerful man in a orange shirt standing in front of an audience holding a tablet and using hand gestures to interact with the audience.
Growth Shares

3 amazing ASX growth shares that continue to stand out

Looking for growth options? Here are three to consider.

Read more »

Person pointing finger on on an increasing graph which represents a rising share price.
Growth Shares

2 ASX shares tipped to grow at least 50% in the next 12 months

These stocks could be some of the best ones to own today.

Read more »

Scared looking people on a rollercoaster ride representing volatility.
Growth Shares

What's driving the wild swings in Telix shares?

The ASX biotech stock offers high-growth potential, but it comes with volatility.

Read more »

An executive in a suit smooths his hair and laughs as he looks at his laptop feeling surprised and delighted.
Growth Shares

3 stellar ASX growth shares to buy now with 30% to 70% upside

Analysts have buy ratings and lofty price targets on these shares.

Read more »

Person using a calculator with four piles of coins, each getting higher, with trees on them.
Growth Shares

2 ASX shares that I rate as buys today for both growth and dividends!

These businesses have plenty going for them. I’m calling them buys…

Read more »

Two excited woman pointing out a bargain opportunity on a laptop.
Share Market News

NextDC shares rocket 27% higher: Buy, hold or sell?

Can NextDC shares keep climbing higher, or have they now peaked?

Read more »

A woman on a green background points a finger at graphic images of molecules, a rocket, light bulbs, and scientific symbols as she smiles.
Growth Shares

3 exciting ASX shares you won't want to miss out on

These ASX shares are not just growing. They are expanding into much larger opportunities.

Read more »